Furthermore, higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration in AD, which provides evidence that sTREM2 may be protective against the development of AD (Franzmeier et al., 2020). The gene discussed is CSF2; the disease is Alzheimer disease.